News

The urology ultrasound devices market is projected to grow at a CAGR of 6%, driven by the rising prevalence of urological ...
Patients who are good candidates for fusion biopsy are those with high blood prostate-specific antigen levels and those who have undergone standard ultrasound-guided random needle biopsy to screen ...
Inc. reaches a milestone in prostate cancer diagnostics with its clinically validated SUREcore® biopsy needle and coreCARE® ...
The doctor puts an ultrasound probe into your rectum. They might take samples of tissue from the prostate during this test. This is a TRUS guided biopsy. It can help to diagnose prostate cancer. You ...
In a study published recently in JAMA, the researchers conducted the first randomized trial, named the OPTIMUM trial, to compare micro-ultrasound (microUS) with MRI-guided biopsy for prostate cancer.
The researchers wanted to determine if high-resolution micro-ultrasonography-guided biopsy was better than MRI fusion ... has the potential for reaching men at risk of prostate cancer worldwide.” ...
A trial found no meaningful difference in detection of clinically significantly prostate ... guided biopsy and combined microultrasonography/MRI biopsy were noninferior to conventional MRI ...
Micro-ultrasound–guided biopsies were found ... procedures to perform an accurate targeted biopsy into the most worrisome regions of the prostate. “Proceeding directly to a micro-ultrasound ...
To perform prostate cancer biopsies, doctors use a technology called MRI fusion-guided biopsy. This technique combines MRI with a transrectal ultrasound to more precisely sample prostate tissue. The ...
Adopting the new tool, named micro-ultrasound ... as effectively as MRI-guided biopsy, with similar rates of detection across all arms of the trial. Prostate cancer is the most diagnosed ...
OPTIMUM is the first randomized trial to compare micro-ultrasound (microUS) guided biopsy with MRI-guided biopsy for prostate cancer. It involved 677 men who underwent biopsy at 19 hospitals ...
Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ ...